Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

0.6058
Delayed Data
As of 3:59pm ET
 -0.0378 / -5.87%
Today’s Change
0.58
Today|||52-Week Range
8.50
-87.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues6.1M4.6M5.2M3.9M
 
 
 
 
 
Depreciation And Amortization89.0K132.0K249.0K293.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.0M------
 
 
General Expenses17.3M26.4M32.6M49.1M
 
 
 
 
 
Research And Development11.5M18.1M22.8M36.7M
 
 
 
 
 
Total Operating Expenses17.4M26.5M32.9M49.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-21.9M-27.7M-45.5M
 
 
 
 
 
Other Expenses-2.0K-36.0K-42.0K-57.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.3M-21.7M-27.2M-44.3M
 
 
 
 
 
Preferred Dividend-228.0K0.000.000.00
 
 
Net Income-11.3M-21.7M-27.2M-44.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.7M9.8M15.1M20.8M
 
 
 
 
 
Shares To Calculate EPS Diluted13.7M9.8M15.1M20.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.84-$2.22-$1.80-$2.13
 
 
 
 
 
EPS Diluted-$0.84-$2.22-$1.80-$2.13